Home » Takashi Iseki – Kawasumi Laboratories
More recent news
- Boston Scientific resumes study of pulse field ablation as first-line AFib therapy
- Solventum raises guidance again after beating The Street in Q3
- Baxter expects $200M hit from hurricane, decreases full-year forecast
- Insulet stock rises on Q3 beat, raised sales guidance
- Johnson & Johnson MedTech wins FDA nod for Varipulse PFA